Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-21-000666
Filing Date
2021-07-28
Accepted
2021-07-28 15:31:06
Documents
52
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pktx_10q-063021.htm   iXBRL 10-Q 692980
2 EXHIIBT 31.1 ex31x1.htm EX-31.1 9949
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 8972
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 6031
  Complete submission text file 0001079973-21-000666.txt   3722744

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pktx-20210630.xsd EX-101.SCH 28782
6 XBRL CALCULATION FILE pktx-20210630_cal.xml EX-101.CAL 26050
7 XBRL DEFINITION FILE pktx-20210630_def.xml EX-101.DEF 129428
8 XBRL LABEL FILE pktx-20210630_lab.xml EX-101.LAB 208166
9 XBRL PRESENTATION FILE pktx-20210630_pre.xml EX-101.PRE 195671
10 EXTRACTED XBRL INSTANCE DOCUMENT pktx_10q-063021_htm.xml XML 682316
Mailing Address 412 MULBERRY STREET MARIETTA OH 45750
Business Address 412 MULBERRY STREET MARIETTA OH 45750 304-299-5070
ProtoKinetix, Inc. (Filer) CIK: 0001128189 (see all company filings)

EIN.: 943355026 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32917 | Film No.: 211122257
SIC: 2834 Pharmaceutical Preparations